E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression
Authors
Keywords
-
Journal
CARDIOVASCULAR RESEARCH
Volume 104, Issue 3, Pages 412-422
Publisher
Oxford University Press (OUP)
Online
2014-10-24
DOI
10.1093/cvr/cvu222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The p53 family and VEGF regulation: “It’s complicated”
- (2013) Morvarid Farhang Ghahremani et al. CELL CYCLE
- Cardiovascular gene therapy with vascular endothelial growth factors
- (2013) Seppo Ylä-Herttuala GENE
- Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis
- (2013) Junlan Zhou et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level
- (2013) T. Arcondeguy et al. NUCLEIC ACIDS RESEARCH
- The role of E2F-1 and downstream target genes in mediating ischemia/reperfusion injury in vivo
- (2011) Ekaterini Angelis et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- CXCR4-Mediated Bone Marrow Progenitor Cell Maintenance and Mobilization Are Modulated by c-kit Activity
- (2010) Min Cheng et al. CIRCULATION RESEARCH
- Promotion of CHIP-Mediated p53 Degradation Protects the Heart From Ischemic Injury
- (2010) Atsuhiko T. Naito et al. CIRCULATION RESEARCH
- The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
- (2010) G Merdzhanova et al. ONCOGENE
- Molecular Regulation of Human Placental Growth Factor (PlGF) Gene Expression in Placental Villi and Trophoblast Cells is Mediated via the Protein Kinase A Pathway
- (2010) Christophe Depoix et al. Reproductive Sciences
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Regulation of Vascular Contractility and Blood Pressure by the E2F2 Transcription Factor
- (2009) Junlan Zhou et al. CIRCULATION
- Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression
- (2009) Yao Liang Tang et al. CIRCULATION RESEARCH
- Reversible regulation of the retinoblastoma protein/E2F-1 pathway during “reverse cardiac remodelling” after ventricular unloading
- (2009) Jeremias Wohlschlaeger et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Regulation of collagen-derived antiangiogenic factors by p53
- (2008) Sarah Assadian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antagonism of E2F-1 regulated Bnip3 transcription by NF- B is essential for basal cell survival
- (2008) J. Shaw et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A– and Placental Growth Factor–Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression
- (2007) Helena Viita et al. CIRCULATION RESEARCH
- The Cell Cycle Factor E2F-1 Activates Bnip3 and the Intrinsic Death Pathway in Ventricular Myocytes
- (2007) Natalia Yurkova et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started